News
"...treating the cause rather than the symptom."
Ben Change, CEO
We strive to change the standard of care and serve patients who suffer from disease brought on by inflammation. accelerating advancements in science and medicine.
Our goal is to offer better care and first-line targeted therapies in the areas of hematology, oncology, neurology, and lung disorders.
Our goal is to offer better care and first-line targeted therapies in the areas of hematology, oncology, neurology, and lung disorders.
Press Release Published announcing Equity Crowd Funding Campaign
PhorMed Inc. (PhorMed or Company) recently filed a Form C for the purpose of launching a Regulatory CF, equity crowdfunding campaign, on the platform WeFunder. For the full article click here